ANCA-associated Vasculitis - 103 Studies Found

Recruiting : The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach
: Granulomatosis With Polyangiitis
: 2013-09-06
:
  • Drug: Prednisone 5 mg/day Subj
Recruiting : Pediatric Vasculitis Initiative
:
  • Wegeners Granulomatosis (Granulomatosis With Polyangiitis)
  • Microscopic Polyangiitis
    • : 2013-11-27
Recruiting : Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
: Granulomatosis With Polyangiitis
: 2013-01-01
:
  • Other: Blood samples and clinical data

Not yet recruiting : Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome
: Churg-Strauss Syndrome
: 2016-03-14
: Biological: HPC cell infusion Administration of total lymp
Recruiting : One-Time DNA Study for Vasculitis
:
  • Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)
  • Giant Cell Arteritis
  • : 2010-10-22
Recruiting : American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
:
  • Wegener's Granulomatosis
  • Microscopic Polyangiitis
  • Churg St
    : 2010-02-09
Recruiting : Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides
:
  • Wegener's Granulomatosis
  • Churg-Strauss Syndrome
  • Microscopi
    : 2008-09-11
    :
    • Drug: Methotrexate
    • Drug: Cyclophosphamide
Completed : Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome
: Churg Strauss Syndrome
: 2008-07-14
: Drug: mepolizumab 750 mg mepolizumab iv q4wk until week 32
Completed : Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome
: Churg Strauss Syndrome
: 2007-09-07
: Biological: Mepolizumab IV mepolizumab, 750 mg Other
Completed : CHUSPAN SCS BP Treatment of Churg–Strauss Syndrome Without Poor-Prognosis Factors
: Churg-Strauss Syndrome
: 2006-11-13
:
  • Drug: azathioprine
  • Drug: cyclophosphamide
<<< Previous | Next >>>